InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
Singh D, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Lange P, Lettis S, Lipson DA, Mannino D, Martin N, Martinez FJ, Miller BE, Wise R, Zhu CQ, Lomas D.
Singh D, et al. Among authors: lange p.
Respir Res. 2021 Apr 28;22(1):130. doi: 10.1186/s12931-021-01706-y.
Respir Res. 2021.
PMID: 33910578
Free PMC article.
Clinical Trial.